Metraipolis › archive › dc_2da76f5aab19
Investigating the impact of Glucagon-like peptide-1 therapy on total shoulder arthroplasty outcomes — Europe PMC PMID:42622874
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42622874
- DOI
- 10.1007/s00264-[numero omesso]-z
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-08T05:11:38.881Z
- SHA-256 of the archived text
5551bfd2a7b0cd47a9f169534514b6b843b10c58b6ace8d8b8538b67ecf3c8ae- Stable URL of this page
https://metraipolis.com/documento/dc_2da76f5aab19
How to cite
Investigating the impact of Glucagon-like peptide-1 therapy on total shoulder arthroplasty outcomes — Europe PMC PMID:42622874 — Europe PMC (en), https://europepmc.org/article/MED/42622874 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2da76f5aab19 (Metraipolis archive dc_2da76f5aab19, sha256 5551bfd2a7b0cd47a9f169534514b6b843b10c58b6ace8d8b8538b67ecf3c8ae)
BibTeX
@misc{dc2da76f5aab19,
title = {Investigating the impact of Glucagon-like peptide-1 therapy on total shoulder arthroplasty outcomes — Europe PMC PMID:42622874},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42622874},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2da76f5aab19; sha256 5551bfd2a7b0cd47a9f169534514b6b843b10c58b6ace8d8b8538b67ecf3c8ae},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42622874. Agents can read the archived copy with the MCP tool read_document.